InsidersTradesSigma
Explore the full record of transactions filed by Poole Sandra, Director. Director active across 1 companies, notably Travere Therapeutics, Inc.. In total, 3 reports have been logged. The latest transaction was filed on 11 May 2022 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
3 of 3 declarations
Sandra Poole is a Director at Travere Therapeutics, Inc. She plays a key role in overseeing the company's activities and making strategic decisions. Her experience is valuable for guiding Travere towards sustainable growth and optimal performance.